DD252540A5 - Verfahren zur herstellung von amorphen benzimidazolderivaten - Google Patents

Verfahren zur herstellung von amorphen benzimidazolderivaten Download PDF

Info

Publication number
DD252540A5
DD252540A5 DD86296688A DD29668886A DD252540A5 DD 252540 A5 DD252540 A5 DD 252540A5 DD 86296688 A DD86296688 A DD 86296688A DD 29668886 A DD29668886 A DD 29668886A DD 252540 A5 DD252540 A5 DD 252540A5
Authority
DD
German Democratic Republic
Prior art keywords
acid
amorphous
formula
compound
solution
Prior art date
Application number
DD86296688A
Other languages
German (de)
English (en)
Inventor
Richard A Runkel
Original Assignee
������@M���]@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@M���]@���Kk�� filed Critical ������@M���]@���Kk��
Publication of DD252540A5 publication Critical patent/DD252540A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • C07D235/32Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD86296688A 1985-11-27 1986-11-26 Verfahren zur herstellung von amorphen benzimidazolderivaten DD252540A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80250885A 1985-11-27 1985-11-27

Publications (1)

Publication Number Publication Date
DD252540A5 true DD252540A5 (de) 1987-12-23

Family

ID=25183897

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86296688A DD252540A5 (de) 1985-11-27 1986-11-26 Verfahren zur herstellung von amorphen benzimidazolderivaten

Country Status (14)

Country Link
EP (1) EP0224257A1 (ja)
JP (1) JPS62155264A (ja)
CN (1) CN86108096A (ja)
AU (1) AU6569986A (ja)
BR (1) BR8605798A (ja)
DD (1) DD252540A5 (ja)
DK (1) DK569686A (ja)
FI (1) FI864813A (ja)
HU (1) HU198025B (ja)
IL (1) IL80768A0 (ja)
IN (1) IN164294B (ja)
NO (1) NO864740D0 (ja)
PT (1) PT83811B (ja)
ZA (1) ZA868962B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102452987A (zh) * 2010-10-28 2012-05-16 桂林南药股份有限公司 一种不定形晶型阿苯达唑的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS601101A (ja) * 1983-06-15 1985-01-07 Yuukou Yakuhin Kogyo Kk 水性懸濁農薬製剤
DE3347579A1 (de) * 1983-12-30 1985-07-11 Hoechst Ag, 6230 Frankfurt Zubereitungen schwer wasserloeslicher anthelminthika und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HUT42076A (en) 1987-06-29
AU6569986A (en) 1987-06-04
FI864813A0 (fi) 1986-11-26
CN86108096A (zh) 1987-07-08
DK569686D0 (da) 1986-11-26
IN164294B (ja) 1989-02-11
PT83811A (en) 1986-12-01
DK569686A (da) 1987-05-28
HU198025B (en) 1989-07-28
BR8605798A (pt) 1987-08-25
NO864740D0 (no) 1986-11-26
EP0224257A1 (en) 1987-06-03
ZA868962B (en) 1988-07-27
JPS62155264A (ja) 1987-07-10
PT83811B (en) 1988-03-15
FI864813A (fi) 1987-05-28
IL80768A0 (en) 1987-02-27

Similar Documents

Publication Publication Date Title
EP0128482B1 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
EP0128483B1 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
DE2815621C2 (ja)
EP1750700A1 (de) Flüssige zubereitung für die veterinärmedizin; verfahren zu deren herstellung und deren verwendung
AT400674B (de) Pharmazeutische pleuromutilin-zubereitung
EP0529500B1 (de) Arzneimittel zur Behandlung von Abstossungsreaktionen bei Organverpflanzungen
EP1513500B1 (de) Pharmazeutische zubereitungen zur oralen anwendung enthaltend pradofloxacin-beladene ionentauscherharze sowie strukturviskose gelbildner als verdicker
JP5451601B2 (ja) 安定な非水性ポアオン組成物
DE60018200T2 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
DE69221454T2 (de) Systemisch gegen Ektoparasiten anwendbare Juvenilhormone
DE60017465T2 (de) Kombination aus fluazuron und ivermectin gegen parasiten
DE2143570C3 (de) Arzneimittel zur Bekämpfung von Leberegelinfektionen bei Säugern
DE60100666T2 (de) Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen
DD252540A5 (de) Verfahren zur herstellung von amorphen benzimidazolderivaten
EP0147767A2 (de) Zubereitungen schwer wasserlöslicher Anthelminthika und Verfahren zu ihrer Herstellung
EP0224249A1 (en) Amorphous benzimidazole derivatives
DE3530780A1 (de) Verwendung von 5-(3-n-butyloxalylaminophenyl)-tetrazol
DE2509346A1 (de) Parasiticides mittel
DE69720016T2 (de) Nodulisporinsäurederivate
EP0007616B1 (de) Isothiocyanobenzthiazolderivat, Verfahren zu seiner Herstellung und seine Anwendung in anthelmintischen Mitteln
DE68910220T2 (de) Veterinäre Zusammensetzungen zur Verwendung gegen Endoparasiten und Verfahren zu ihrer Herstellung.
DE2617198C2 (de) 6-n-Propoxybenzthiazol-2-methylcarbamat, Verfahren zu seiner Herstellung und es enthaltende Arzneimittel
DE2257360C2 (de) 1-(2-Chloräthyl)-1-nitroso-3-[(2-methyl-4-amino-pyrimidin-5-yl)methyl]harnstoff und Verfahren zu seiner Herstellung
EP1434761B1 (de) Salze von guanidinderivaten und pharmazeutische zubereitungen daraus
DE3033814C2 (de) Arzneimittelzubereitung von N↑4-Acylcytosinarabinosiden